The Role of Autologous Blood Stem Cells in Support of High-dose Therapy for Multiple Myeloma

This publication has 24 references indexed in Scilit:

• Mobilization of haemopoietic stem cells by cyclophosphamide into the peripheral blood of patients with haematological malignancies
  Clinical and Laboratory Haematology, 2008
• Analysis of tumor‐specific immunoglobulin gene rearrangement in peripheral blood B‐cells of multiple myeloma patients
  American Journal of Hematology, 1991
• Blood-derived haematopoietic cell transplants: blood to blood?
  The Lancet, 1991
• Monoclonal gammopathies: New approaches to clinical problems in diagnosis and prognosis
  Blood Reviews, 1989
• Detection of monoclonal B lymphocytes in bone marrow and peripheral blood of multiple myeloma patients by immunoglobulin gene rearrangement studies
  British Journal of Haematology, 1989
• INTENSIVE TREATMENT OF MULTIPLE MYELOMA AND CRITERIA FOR COMPLETE REMISSION
  The Lancet, 1989
• Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma.
  The Journal of Experimental Medicine, 1989
• No detectable malignant B cells in the peripheral blood of patients with multiple myeloma
  British Journal of Haematology, 1989
• High levels of circulating haemopoietic stem cells in very early remission from acute non‐lymphoblastic leukaemia and their collection and cryopreservation
  British Journal of Haematology, 1984
• Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation.
  The Journal of Experimental Medicine, 1979